Vladimir Jovasevic, Ph.D.
Affiliations: | 2004 | University of Illinois at Chicago, Health Sciences Center, Chicago, IL 60612, United States |
Area:
Biochemistry, Immunology, Molecular Biology, OncologyGoogle:
"Vladimir Jovasevic"Mean distance: (not calculated yet)
Parents
Sign in to add mentorMargalit B. Mokyr | grad student | 2004 | University of Illinois at Chicago, Health Sciences Center | |
(Mechanism of potentiation of tumor -eradicating immunity by melphalan and by CTLA-4 blockade.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Guedea AL, Schrick C, Guzman YF, et al. (2011) ERK-associated changes of AP-1 proteins during fear extinction. Molecular and Cellular Neurosciences. 47: 137-44 |
Jovasevic V, Liang L, Roizman B. (2008) Proteolytic cleavage of VP1-2 is required for release of herpes simplex virus 1 DNA into the nucleus. Journal of Virology. 82: 3311-9 |
Jovasevic VM, Gorelik L, Bluestone JA, et al. (2004) Importance of IL-10 for CTLA-4-mediated inhibition of tumor-eradicating immunity. Journal of Immunology (Baltimore, Md. : 1950). 172: 1449-54 |
Donepudi M, Jovasevic VM, Raychaudhuri P, et al. (2003) Melphalan-induced up-regulation of B7-1 surface expression on normal splenic B cells. Cancer Immunology, Immunotherapy : Cii. 52: 162-70 |
Jovasevic VM, Mokyr MB. (2001) Melphalan-induced expression of IFN-beta in MOPC-315 tumor-bearing mice and its importance for the up-regulation of TNF-alpha expression. Journal of Immunology (Baltimore, Md. : 1950). 167: 4895-901 |